Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein kinase C epsilon type (PKCε) – Receptor for activated C kinase 1 (RACK1) protein-protein interface is a critical regulatory site for the spatial and temporal control of PKCε signaling (UniProt Q02156; UniProt P63244). PKCε is a novel, calcium-independent serine/threonine kinase that requires translocation to specific subcellular compartments to exert its biological effects. RACK1 acts as a molecular scaffold that binds to the activated form of PKCε, facilitating its movement to target membranes and substrates (Mochly-Rosen et al., Science, 1991). This interaction is a key mediator in various physiological processes, including cardiac preconditioning against ischemia and the modulation of pain sensitivity (Journal of Biological Chemistry, 2012). In disease contexts, the PKCε-RACK1 interface is implicated in the progression of certain cancers and the development of alcohol dependence (Nature Reviews Drug Discovery, 2006). Therapeutic strategies targeting this interface often utilize peptide mimetics, such as the inhibitor εV1-2 or the activator ψεRACK, to selectively modulate PKCε activity without affecting other PKC isoforms (KAI Pharmaceuticals). By disrupting or stabilizing this specific protein-protein interaction, researchers aim to treat conditions like myocardial infarction and chronic pain with high precision.
Modulation of the physical interaction between Protein kinase C epsilon type and its anchoring protein Receptor for activated C kinase 1 to either inhibit or promote the translocation and localized activity of the kinase.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C epsilon type – Receptor for activated C kinase 1 protein-protein interface (PKCε-RACK1 PPI).